Topic: Supply Chain Management
Virtually all brands face the threat of counterfeiting and gray market trading.
There has been a lot of talk about how blockchain technology can better protect the U.S. drug supply chain. Merck intends to test that theory.
The costs for drugmakers to alter supply chains to keep drugs available in the case of a hard Brexit are running into the hundreds of millions of dollars.
Pfizer’s executive vice president and president of global supply, Anthony J. Maddaluna, is retiring from the pharma giant after more than 41 years with the company.